EUVIMEDEUVIMED entdecken
Crossref

Exploring the Utility of Cell‐Penetrating Peptides as Vehicles for the Delivery of Distinct Antimalarial Drug Cargoes

Caitlin L Gare, Isabella R Palombi, Andrew M White, Marina Chavchich, Michael D Edstein, Aaron Lock, Vicky M Avery, David J Craik, Brendan J McMorran, Nicole Lawrence, Lara R Malins iD

ChemMedChem · 2025

DOI: 10.1002/cmdc.202400637 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, 2025. Verfasst von Caitlin L Gare und 10 weiteren Autor:innen. Beteiligte Einrichtung: Research School of Chemistry, The Australian National University, Canberra, ACT, 2601, Australia. Hauptthemen laut MEDLINE: Antimalarials, Cell-Penetrating Peptides, Plasmodium falciparum, Drug Delivery Systems. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 85 Literaturangaben. Gefördert von: National Health and Medical Research Council, Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, US Department of Defense.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The devastating impact of malaria includes significant mortality and illness worldwide. Increasing resistance of the causative parasite, Plasmodium , to existing antimalarial drugs underscores a need for additional compounds with distinct modes of action in the therapeutic development pipeline. Here we showcase peptide‐drug conjugates (PDCs) as an attractive compound class, in which therapeutic or lead antimalarials are chemically conjugated to cell‐penetrating peptides. This approach aims to enhance selective uptake into Plasmodium ‐infected red blood cells and impart additional cytotoxic actions on the intraerythrocytic parasite, thereby enabling targeted drug delivery and dual modes of action. We describe the development of PDCs featuring four compounds with antimalarial activity—primaquine, artesunate, tafenoquine and methotrexate—conjugated to three cell‐penetrating peptide scaffolds with varied antiplasmodial activity, including active and inactive analogues of platelet factor 4 derived internalization peptide (PDIP), and a cyclic polyarginine peptide. Development of this diverse set of PDCs featured distinct and adaptable conjugation strategies, to produce conjugates with in vitro antiplasmodial activities ranging from low nanomolar to low micromolar potencies according to the drug cargo and bioactivity of the partner peptide. Overall, this study establishes a strategic and methodological framework for the further development of dual mode of action peptide‐drug antimalarial therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntimalarialsCell-Penetrating PeptidesPlasmodium falciparumDrug Delivery SystemsDrug CarriersHumansStructure-Activity RelationshipParasitic Sensitivity TestsMolecular StructureErythrocytesDose-Response Relationship, Drug

Stichwörter der Autor:innen

BioconjugationCell-penetrating peptideClick chemistryMalariaPeptide-drug conjugate

Substanzen

AntimalarialsCell-Penetrating PeptidesDrug Carriers

Autor:innen und Institutionen

  • Research School of Chemistry, The Australian National University, Canberra, ACT, 2601, Australia.
  • Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The Australian National University, Canberra, ACT, 2601, Australia.
  • Department of Drug Evaluation, Australian Defence Force Malaria and Infectious Disease Institute, Brisbane, QLD, 4051, Australia.
  • Discovery Biology, Centre for Cellular Phenomics, School of Environment and Science, Griffith University, Brisbane, QLD, 4111, Australia.
  • Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, 4072, Australia.
  • Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Queensland, Brisbane, QLD, 4072, Australia.

ORCID-Profile: Lara R Malins

Förderung

  • National Health and Medical Research Council
  • Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science
  • US Department of Defense
  • Australian Red Cross Lifeblood
  • Australian Research Council
  • U.S. Department of Defense

Zitieren

APA

Gare, C. L., Palombi, I. R., White, A. M., Chavchich, M., Edstein, M. D., Lock, A., Avery, V. M., Craik, D. J., McMorran, B. J., Lawrence, N., & Malins, L. R. (2025). Exploring the Utility of Cell‐Penetrating Peptides as Vehicles for the Delivery of Distinct Antimalarial Drug Cargoes. ChemMedChem. https://doi.org/10.1002/cmdc.202400637

Vancouver

Gare CL, Palombi IR, White AM, Chavchich M, Edstein MD, Lock A, et al. Exploring the Utility of Cell‐Penetrating Peptides as Vehicles for the Delivery of Distinct Antimalarial Drug Cargoes. ChemMedChem. 2025. doi:10.1002/cmdc.202400637

BibTeX
@article{Gare2025,
  author = {Gare, Caitlin L and Palombi, Isabella R and White, Andrew M and Chavchich, Marina and Edstein, Michael D and Lock, Aaron and Avery, Vicky M and Craik, David J and McMorran, Brendan J and Lawrence, Nicole and Malins, Lara R},
  title = {Exploring the Utility of Cell‐Penetrating Peptides as Vehicles for the Delivery of Distinct Antimalarial Drug Cargoes},
  journal = {ChemMedChem},
  year = {2025},
  doi = {10.1002/cmdc.202400637}
}
Kostenlos starten →